Clinicopathological, immune and molecular correlates of PD-L2 methylation in gastric adenocarcinomas
Clinicopathological, immune and molecular correlates of PD-L2 methylation in gastric adenocarcinomas
复制标题
DOI：
10.2217/epi-2018-0149
复制
发表时间：
2019-05-01
期刊：
影响因子：
3.8
通讯作者：
Dietrich, Dimo
中科院分区：
文献类型：
--
作者：
Lingohr, Philipp;Dohmen, Jonas;Dietrich, Dimo
Aim: We investigated the significance of PD-L2 DNA methylation in gastric adenocarcinomas. Methods: We analyzed the methylation at different CpG sites within the PD-L2-encoding gene PDCD1LG2 with regard to correlations and associations with gene expression, clinicopathological parameters, molecular features and immune cell infiltrates in two publicly available cohorts (The Cancer Genome Atlas and Singapore cohorts) of a total of 594 gastric adenocarcinoma patients. Results: PD-L2 methylation is significantly associated with transcriptional activity, survival, Epstein-Barr virus infection, PD-L2 gene amplification, CD8(+) T-cell infiltration, microsatellite instability and high mutational load (tumor mutational burden, hypermutation). Conclusion: PD-L2 methylation is associated with known predictive biomarkers of response to anti-PD-1 immunotherapies.
